BellRing Brands (BRBR) Bearish Setup: AI Points to Put Options

AI-powered insights updated on 11/4/2025.

AI Signal: Strongly Bearish outlook with confirming negative momentum.
BRBR is exhibiting a strong downtrend, driven by declining profitability and weak momentum indicators. Traders should consider put options to capitalize on potential further downside in the next 1-3 months.

Trend Strength

Price below 50D MA at $35.64

R S I Momentum

Current RSI at 20.34, weakening from 34.72

Volume Surge

52.42% above 30-day average

BRBR Earnings Date & Key Events

Key upcoming dates for BRBR that could impact its stock price.
DateEventType
11/18/2025BRBR Earnings
BRBR-Specific

Full Analysis Breakdown

About

BellRing Brands is a global convenient nutrition company. Its core business revolves around 'Premier Protein' and 'Dymatize' brands. 'Premier Protein' offers ready-to-drink (RTD) protein shakes and protein powders, targeting a broad consumer base seeking everyday nutrition. 'Dymatize' focuses on sports nutrition, offering protein powders like ISO.100 to fitness enthusiasts. BellRing distributes its products through diverse channels, including club stores, food, drug, and mass (FDM) retailers, eCommerce platforms, specialty stores, and convenience stores. The company differentiates itself through strong brand marketing, effective customer relationship management, superior product quality, product innovation, and an efficient supply chain.

News Summary

No relevant news was found for this stock today.

Technicals

BRBR's technical outlook is decidedly bearish. The stock price has experienced a significant decline over the past 90 days, dropping from approximately $58 to around $30. The price is currently below its 50-day SMA of $35.81 and significantly below its 200-day SMA of $57.53, confirming a strong downtrend. Momentum indicators are also weak; the RSI is at 27.99, indicating oversold conditions, but in a strong downtrend, this can persist. The MACD is negative at -1.62, and trending downwards, suggesting continued bearish momentum. The ADX is elevated at 49.79, signaling a strong trend, which in this case is downwards. The stochastic oscillator is at 4.76, which typically indicates an oversold condition, but the overall trend suggests limited upward potential. Given the strong downtrend, low RSI, and negative MACD, a further decline is likely in the next 1-3 months. There are no clear reversal signals present.

Management Discussion

BellRing Brands' MD&A presents a mixed picture. For the three months ended June 30, 2025, 'Net Sales' increased by $32.1 million, or 6%, driven by Premier Protein and Dymatize products. However, 'Operating Profit' decreased significantly by $66.8 million, or 60%, primarily due to a $68.1 million provision for legal matters and higher net product costs. For the nine months ended June 30, 2025, 'Net Sales' increased by $228.0 million, or 16%, but 'Operating Profit' decreased by $20.4 million, or 7%, due to the legal provision, higher costs, and increased expenses. 'Cash provided by operating activities' decreased by $68.0 million to $91.5 million for the nine months ended June 30, 2025, compared to $159.5 million in the prior year, due to increased inventory levels, tax payments and interest payments. The company 'expect[s] to generate positive cash flows from operations' and believes its resources will be sufficient for future needs, but this is dependent on economic conditions and competitive pressures. The company also mentions inflationary pressures on input costs, which could adversely impact the business if they cannot be offset by price increases or cost savings. The presence of a large legal provision and declining operating cash flow raise concerns, overshadowing the net sales growth.

Earnings Call

BellRing Brands' Q3 2025 earnings call projects a moderately bullish outlook. The company reported net sales of $548 million, up 6% year-over-year, and adjusted EBITDA of $120 million. While slightly ahead of expectations, management has 'tightened' their fiscal '25 guidance, keeping the midpoint unchanged, with net sales now projected between $2.28 billion and $2.32 billion and adjusted EBITDA between $480 million and $490 million. Premier Protein's net sales grew 6%, driven by volume and pricing, with shake consumption dollar growth significantly outpacing shipment dollar growth at 19%. Darcy Horn Davenport emphasized the 'long runway of growth' for the ready-to-drink shake category and highlighted Premier Protein's strong brand fundamentals, including a 25% market share and 21.6% household penetration. The company is investing in brand support, distribution expansion, and innovation, including new indulgence and almond milk shake lines. While facing gross margin pressures in Q4 due to increased promotional spend and input cost inflation, the company anticipates significant SG&A leverage. Overall, the company appears well-positioned for continued growth.

Financials

BRBR's financial performance presents a mixed but slightly concerning picture. Revenue has shown an overall increase, rising from $430.4M in Q1 2024 to $547.5M in Q3 2025, indicating top-line growth. However, the gross profit ratio has fluctuated, starting at 0.34 in Q1 2024, peaking at 0.37 in Q4 2024, and then declining to 0.35 in the most recent quarter, suggesting potential pressure on profitability. The operating cash flow has also been highly variable, with the latest quarter showing a significant outflow of -$51.2M, a stark contrast to the $74.2M inflow in Q1 2024, raising concerns about cash management. Furthermore, the company's solvency is a major red flag, with total debt increasing substantially from $832.1M in Q1 2024 to $1009.0M in Q3 2025, indicating a significant rise in leverage. While revenue is growing, the declining gross margin, negative operating cash flow in the latest quarter, and escalating debt levels paint a worrisome picture for BRBR's near-term financial health.

Fundamentals

The company demonstrates a moderately bullish profile, characterized by solid revenue growth and improving profitability. Revenue has consistently increased, indicating strong market demand. The gross margin exhibits stability, suggesting efficient cost management. Return on Equity (ROE) has shown positive movement, signaling enhanced profitability and efficient use of shareholder equity. The Price-to-Earnings (P/E) ratio, while elevated, might be justifiable given the growth trajectory and positive ROE trend. The Debt-to-Equity ratio shows a slight increase, which warrants monitoring, but is counterbalanced by a healthy Current Ratio, implying sufficient liquidity to meet short-term obligations. Overall, the company presents a favorable picture with growth and profitability, though the leverage should be watched closely. The combination of growth and profitability suggests potential for continued positive performance over the next 12 months.

Unlock Data-Driven Options Setups
Go beyond static reports with an interactive dashboard
Access daily, top-rated Call & Put setups
Track performance for every signal we issue
Start Your Free 30-Day Trial
Disclaimer

The information provided on this page is for informational purposes only and does not constitute investment advice, financial advice, trading advice, or any other sort of advice and you should not treat any of the page's content as such. ProfitScout does not recommend that any security should be bought, sold, or held by you. Do conduct your own due diligence and consult your financial advisor before making any investment decisions.

Related Stocks

    We Use Cookies

    We use cookies to enhance your experience, analyze site traffic, and for marketing purposes. By clicking "Accept," you agree to our use of cookies. Read our Privacy Policy.